Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-009041

President & CEO acquired 430 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
USMAN NASSIM President & CEO 2020-02-10 Grant or award +430 $6.23 $2,679 7,010 D: show line 1 in the form
Loading xslF345X03/doc4.xml…